Cargando…

The Effects of a Ketogenic Medium-Chain Triglyceride Diet on the Feces in Dogs With Idiopathic Epilepsy

Consumption of diets containing medium chain triglycerides have been shown to confer neuroprotective and behavior modulating effects. We aimed to identify metabolic and microbiome perturbations in feces that are associated with consumption of a medium chain triglyceride ketogenic diet (MCT-KD) in do...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pilla, Rachel, Law, Tsz Hong, Pan, Yuanlong, Zanghi, Brian M., Li, Qinghong, Want, Elizabeth J., Lidbury, Jonathan A., Steiner, Joerg M., Suchodolski, Jan S., Volk, Holger Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Veterinary Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783044/ https://www.ncbi.nlm.nih.gov/pubmed/33415132 http://dx.doi.org/10.3389/fvets.2020.541547

Ejemplares similares

Metabolic perturbations associated with the consumption of a ketogenic medium-chain TAG diet in dogs with idiopathic epilepsy
por: Law, Tsz Hong, et al.
Publicado: (2018)

Metabolic fingerprinting of dogs with idiopathic epilepsy receiving a ketogenic medium-chain triglyceride (MCT) oil
por: Berk, Benjamin Andreas, et al.
Publicado: (2022)

A randomised trial of a medium-chain TAG diet as treatment for dogs with idiopathic epilepsy
por: Law, Tsz Hong, et al.
Publicado: (2015)

Dietary medium chain triglycerides for management of epilepsy: New data from human, dog, and rodent studies
por: Han, Felicity Y., et al.
Publicado: (2021)

Prevalence of Clostridioides difficile in Canine Feces and Its Association with Intestinal Dysbiosis
por: Werner, Melanie, et al.
Publicado: (2023)

The effect of phenobarbital treatment on behavioral comorbidities and on the composition and function of the fecal microbiome in dogs with idiopathic epilepsy
por: Watanangura, Antja, et al.
Publicado: (2022)

Metabolic and Immunological Effects of Intermittent Fasting on a Ketogenic Diet Containing Medium-Chain Triglycerides in Healthy Dogs
por: Leung, Y. Becca, et al.
Publicado: (2020)

A multicenter randomized controlled trial of medium‐chain triglyceride dietary supplementation on epilepsy in dogs
por: Berk, Benjamin A., et al.
Publicado: (2020)

Urinary Neurotransmitter Patterns Are Altered in Canine Epilepsy
por: Schmidt, Teresa, et al.
Publicado: (2022)

Microbiota-Related Changes in Unconjugated Fecal Bile Acids Are Associated With Naturally Occurring, Insulin-Dependent Diabetes Mellitus in Dogs
por: Jergens, Albert E., et al.
Publicado: (2019)

Effect of a Ketogenic Medium Chain Triglyceride-Enriched Diet on the Fecal Microbiota in Canine Idiopathic Epilepsy: A Pilot Study
por: García-Belenguer, Sylvia, et al.
Publicado: (2023)

Alterations in the Fecal Microbiome and Metabolome of Horses with Antimicrobial-Associated Diarrhea Compared to Antibiotic-Treated and Non-Treated Healthy Case Controls
por: Arnold, Carolyn, et al.
Publicado: (2021)

Editorial: Epilepsy in veterinary science
por: Fischer, Andrea, et al.
Publicado: (2023)

Quantification of phenobarbital-induced ataxia in dogs with idiopathic epilepsy
por: Sherif, Tamara, et al.
Publicado: (2023)

Fecal Microbial and Metabolic Profiles in Dogs With Acute Diarrhea Receiving Either Fecal Microbiota Transplantation or Oral Metronidazole
por: Chaitman, Jennifer, et al.
Publicado: (2020)

Medium Chain Triglycerides Modulate the Ketogenic Effect of a Metabolic Switch
por: Vandenberghe, Camille, et al.
Publicado: (2020)

The Role of the Canine Gut Microbiome and Metabolome in Health and Gastrointestinal Disease
por: Pilla, Rachel, et al.
Publicado: (2020)

Administration of a Synbiotic Containing Enterococcus faecium Does Not Significantly Alter Fecal Microbiota Richness or Diversity in Dogs With and Without Food-Responsive Chronic Enteropathy
por: Pilla, Rachel, et al.
Publicado: (2019)

Efficacy of medium chain triglyceride oil dietary supplementation in reducing seizure frequency in dogs with idiopathic epilepsy without cluster seizures: a non-blinded, prospective clinical trial
por: Molina, Jenifer, et al.
Publicado: (2020)

The Use of Ketogenic Diet in Pediatric Patients with Epilepsy
por: Misiewicz Runyon, Amanda, et al.
Publicado: (2012)

Characterization of the Fecal Microbiome in Dogs Receiving Medical Management for Congenital Portosystemic Shunts
por: Squire, Nathan, et al.
Publicado: (2022)

Medium-chain Triglyceride Ketogenic Diet as a Treatment Strategy for Adult Super-refractory Status Epilepticus
por: Dutta, Kaustuv, et al.
Publicado: (2022)

Refueling the post COVID-19 brain: potential role of ketogenic medium chain triglyceride supplementation: an hypothesis
por: Juby, Angela G., et al.
Publicado: (2023)

Ketogenic Effects of Multiple Doses of a Medium Chain Triglycerides Enriched Ketogenic Formula in Healthy Men under the Ketogenic Diet: A Randomized, Double-Blinded, Placebo-Controlled Study
por: Nakamura, Kentaro, et al.
Publicado: (2022)

Emulsification Increases the Acute Ketogenic Effect and Bioavailability of Medium-Chain Triglycerides in Humans: Protein, Carbohydrate, and Fat Metabolism
por: Courchesne-Loyer, Alexandre, et al.
Publicado: (2017)

PT599. Effect of single ketogenic diet containing medium chain triglycerides on cognitive functions in elderly adults
por: Matsuo, Junko, et al.
Publicado: (2016)

Octanoic acid a major component of widely consumed medium-chain triglyceride ketogenic diet is detrimental to bone
por: Jain, Shreshta, et al.
Publicado: (2021)

Ketogenic Diet and Epilepsy
por: Ułamek-Kozioł, Marzena, et al.
Publicado: (2019)

Age-associated changes in intestinal health biomarkers in dogs
por: Fernández-Pinteño, Anna, et al.
Publicado: (2023)

Feeding of fish oil and medium-chain triglycerides to canines impacts circulating structural and energetic lipids, endocannabinoids, and non-lipid metabolite profiles
por: Jackson, Matthew I., et al.
Publicado: (2023)

The cecal and fecal microbiomes and metabolomes of horses before and after metronidazole administration
por: Arnold, Carolyn E., et al.
Publicado: (2020)

An fMRI Investigation into the Effects of Ketogenic Medium-Chain Triglycerides on Cognitive Function in Elderly Adults: A Pilot Study
por: Yomogida, Yukihito, et al.
Publicado: (2021)

Effect of oral or injectable supplementation with cobalamin in dogs with hypocobalaminemia caused by chronic enteropathy or exocrine pancreatic insufficiency
por: Chang, Chee‐Hoon, et al.
Publicado: (2022)

Evaluation of the effects of anthelmintic administration on the fecal microbiome of healthy dogs with and without subclinical Giardia spp. and Cryptosporidium canis infections
por: Fujishiro, Madeline A., et al.
Publicado: (2020)

Cyclooxygenase-2 Inhibition as an Add-On Strategy in Drug Resistant Epilepsy—A Canine Translational Study
por: Fischer, Andrea, et al.
Publicado: (2022)

The Ketogenic Effect of Medium-Chain Triacylglycerides
por: Lin, Ting-Yu, et al.
Publicado: (2021)

Medium Chain Triglycerides
por: Sribney, Michael
Publicado: (1968)

A double-blinded randomised dietary supplement crossover trial design to investigate the short-term influence of medium chain fatty acid (MCT) supplement on canine idiopathic epilepsy: study protocol
por: Berk, Benjamin Andreas, et al.
Publicado: (2019)

Neurostimulation as a Method of Treatment and a Preventive Measure in Canine Drug-Resistant Epilepsy: Current State and Future Prospects
por: Nowakowska, Marta, et al.
Publicado: (2022)

Viral Metagenomics Reveals Diverse Viruses in the Feces Samples of Raccoon Dogs
por: Yang, Shixing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u9i3f26pkshubhdup1c690o2gb